Table 2 |
||||||
|
Case-control studies of smokeless tobacco and cancer |
||||||
|
Study |
Country |
Study perioda |
Controlsa |
Sexb |
Exposures studiedc |
Cancers studied (cases)d |
|
|
||||||
|
Broders 1920 [37] |
USA |
NA |
Hospital |
M+F |
Chew, snuff, ST |
Oral (537) |
|
Doll and Hill 1952 [38] |
UK |
1948–1952 |
Hospital |
M |
Chew, snuff |
Lung (1,209) |
|
Moore et al. 1953 [39] |
USA |
1951–1952 |
Hospital |
M |
ST |
Oral (112), face (93) |
|
Wynder et al. 1957 [40] |
Sweden |
1952–1955 |
Hospital |
M |
Chew |
Oral (166), oesophagus (39), larynx (60) |
|
Wynder and Bross 1957 [41] |
USA |
NA |
Hospital |
M |
Chew |
Oral (543) |
|
Peacock et al. 1960 [42] |
USA |
1952–1958 |
Hospital |
M+F |
ST |
Oral (45) |
|
Lockwood 1961 [43] |
Denmark |
1942–1956 |
Population |
M+F |
ST |
Bladder (282) |
|
Wynder and Bross 1961 [44] |
USA |
1956–1959 |
Hospital |
M |
Chew |
Oesophagus (150) |
|
Vogler et al. 1962 [36] |
USA |
1956–1957 |
Hospital |
M+F |
Chew, snuff |
Oral (228) |
|
Vincent and Marchetta 1963 [45] |
USA |
NA |
Hospital |
M |
Snuff |
Oral (66), larynx (23) |
|
Wynder et al. 1963 [46] |
USA |
1957–1960 |
Hospital |
M |
Chew, snuff, ST |
Bladder (300) |
|
Bennington and Laubscher 1968 [47] |
USA |
1951–1956 |
Hospital |
M |
Chew |
Kidney (88) |
|
Dunham et al. 1968 [48] |
USA |
1958–1964 |
Hospital |
M+F |
ST |
Bladder (493) |
|
Martinez 1969 [49] |
Puerto Rico |
1966 |
Hospital, population |
M+F |
Chew |
Oral (221), oesophagus (179) |
|
Keller 1970 [50] |
USA |
1958–1962 |
Hospital |
M |
ST |
Oral (314) |
|
Cole et al. 1971 [51] |
USA |
1967–1968 |
Population |
M+F |
Chew, snuff |
Bladder (470) |
|
Bjelke et al. 1974 [52] |
USA |
NA |
NA |
NA |
Chew |
Colorectal (373), oesophagus (52), stomach (83) |
|
Norway |
NA |
NA |
NA |
Chew |
Colorectal (278), stomach (228) |
|
|
Armstrong et al. 1976 [53] |
UK |
1972–1974 |
Hospital |
M |
ST |
Kidney (96) |
|
Browne et al. 1977 [54] |
UK |
1957–1971 |
Population |
M+F |
Chew |
Oral (75) |
|
Williams and Horm 1977 [55] |
USA |
1969–1971 |
Hospital |
M+F |
ST |
Many types (7,518)e |
|
Wynder and Stellman 1977 [56] |
USA |
1969–1975 |
Hospital |
M |
Chew, snuff, ST |
Oral (593), bladder (589), larynx (387), lung (1,051), oesophagus (183) |
|
Engzell et al. 1978 [57] |
Sweden |
1961–1971 |
Population |
M |
Snuff |
Nose (36) |
|
Howe et al. 1980 [58] |
Canada |
1974–1976 |
Population |
M |
Chew |
Bladder (480) |
|
Westbrook et al. 1980 [59] |
USA |
1955–1975 |
Hospital |
F |
Snuff |
Oral (55) |
|
Pottern et al. 1981 [60] |
USA |
1975–1977 |
Decedent |
M |
Chew, snuff |
Oesophagus (120) |
|
Winn et al. 1981 [61] |
USA |
1975–1978 |
Hospital |
F |
Snuff |
Oral (255) |
|
Mommsen and Aagaard 1983 [62] |
Denmark |
1977–1980 |
Population |
M |
Chew |
Bladder (165) |
|
Wynder et al. 1983 [63] |
USA |
1977–1980 |
Hospital |
M |
Chew, snuff, ST |
Oral (414) |
|
Brinton et al. 1984 [64] |
USA |
1970–1980 |
Hospital, decedent |
M+F |
Chew, snuff, ST |
Nose (160) |
|
McLaughlin et al. 1984 [65] |
USA |
1974–1979 |
Population |
M |
Chew, snuff, ST |
Kidney (313) |
|
Hartge et al. 1985 [66] |
USA |
1977–1978 |
Population |
M |
Chew, snuff, ST |
Bladder (2,240) |
|
Weinberg et al. 1985 [67] |
USA |
1978–1980 |
Decedent, population |
M |
Chew |
Stomach (178) |
|
Goodman et al. 1986 [68] |
USA |
1977–1983 |
Hospital |
M+F |
Chew |
Kidney (267) |
|
Kabat et al. 1986 [69] |
USA |
1976–1983 |
Hospital |
F |
Snuff |
Bladder (152) |
|
Stockwell and Lyman 1986 [70] |
USA |
1982 |
Population |
M+F |
ST |
Oral (1,462), nose (92), larynx (161) |
|
Young et al. 1986 [71] |
USA |
4 yr period |
Hospital |
M+F |
ST |
Oral (317), larynx (179) |
|
Lindquist et al. 1987 [72] |
Sweden |
1980–1983 |
Population |
M |
Snuff |
Leukaemia (76) |
|
Asal et al. 1988 [73] |
USA |
1981–1984 |
Hospital, population |
M |
Snuff |
Kidney (209) |
|
Blot et al. 1988 [74] |
USA |
1984–1985 |
Population |
M+F |
ST |
Oral (1,114) |
|
Falk et al. 1988 [75] |
USA |
1979–1983 |
Hospital |
M+F |
Chew, snuff |
Pancreas (363) |
|
Morris Brown et al. 1988 [76] |
USA |
1982–1984 |
Population |
M |
ST |
Oesophagus (207) |
|
Slattery et al. 1988 [77] |
USA |
1977–1983 |
Population |
M |
Chew, snuff, ST |
Bladder (332) |
|
Spitz et al. 1988 [78] |
USA |
1985–1987 |
Hospital |
M+F |
Chew, snuff, ST |
Oral (185)f |
|
Burch et al. 1989 [79] |
Canada |
1979–1982 |
Population |
M |
Chew, snuff |
Bladder (627) |
|
Franco et al. 1989 [80] |
Brazil |
1986–1988 |
Hospital |
M+F |
ST |
Oral (232) |
|
Zahm et al. 1989 [81] |
USA |
1976–1982 |
Population |
M |
ST |
Soft tissue sarcoma (133) |
|
Farrow et al. 1990 [82] |
USA |
1982–1986 |
Population |
M |
Chew |
Pancreas (148) |
|
Blomqvist et al. 1991 [83] |
Sweden |
NA |
Hospital |
M+F |
Snuff |
Oral (61) |
|
Ghadirian et al. 1991 [84] |
Canada |
1984–1988 |
Population |
M+F |
Chew |
Pancreas (179) |
|
Maden et al. 1992 [85] |
USA |
1985–1989 |
Population |
M |
ST |
Oral (131) |
|
Marshall et al. 1992 [86] |
USA |
1975–1983 |
Population |
M+F |
Chew |
Oral (290) |
|
Morris Brown et al. 1992 [87] |
USA |
1981–984 |
Population |
M |
ST |
Leukaemia (578) |
|
Morris Brown et al. 1992 [88] |
USA |
1981–1984 |
Population |
M |
ST |
Non-Hodgkin's lymphoma (622) |
|
Sterling et al. 1992 [89] |
USA |
1986 |
Population |
M+F |
Snuff, ST |
All cancer (459,792), oral (6,976), all digestive (109,514) |
|
Mashberg et al. 1993 [90] |
USA |
1972–1989 |
Hospital |
M |
Chew, snuff, ST |
Oral (359) |
|
Perry et al. 1993g |
USA |
About 1992 |
Hospital |
M+F |
ST |
Oral (133) |
|
Spitz et al. 1993 [92] |
USA |
1987–1991 |
Hospital |
M+F |
Chew |
Oral (108)f |
|
Chow et al. 1994 [93] |
USA |
1985–1997 |
Population |
M |
Chew |
Bile duct (49) |
|
Hansson et al. 1994 [94] |
Sweden |
1989–1992 |
Population |
M+F |
Chew, snuff |
Stomach (338) |
|
Hardell et al. 1994 [95] |
Sweden |
1974–1978 |
Population |
M |
Snuff |
Non-Hodgkin's lymphoma (105) |
|
Hayes et al. 1994 [96] |
USA |
1986–1989 |
Population |
M |
Chew, snuff, ST |
Prostate (981) |
|
Kabat et al. 1994 [97] |
USA |
1977–1990 |
Hospital |
M+F |
Chew, snuff |
Oral (1,560) |
|
Bundgaard et al. 1995 [98] |
Denmark |
1986–1990 |
Population |
M+F |
Chew |
Oral (161) |
|
McLaughlin et al. 1995 [99] |
5 countriesh |
1989–1991 |
Population |
M+F |
ST |
Kidney (1,732) |
|
Muscat et al. 1995 [100] |
USA |
1977–1993 |
Hospital |
M |
Chew |
Kidney (543) |
|
Muscat et al. 1997 [101] |
USA |
1985–1993 |
Hospital |
M |
Chew, snuff |
Pancreas (290) |
|
Lewin et al. 1998 [102] |
Sweden |
1980–1989 |
Population |
M |
Snuff |
Oral (266), larynx (157), oesophagus (122) |
|
Muscat and Wynder 1998 [103] |
USA |
1977–1980 |
Hospital |
M+F |
Chew, ST |
Oral (128) |
|
Schildt et al. 1998 [104] |
Sweden |
1980–1989 |
Population |
M+F |
Chew, snuff, ST |
Oral (410) |
|
Schwartz et al. 1998 [105] |
USA |
1990–1995 |
Population |
M |
ST |
Oral (165) |
|
Yuan et al. 1998 [106] |
USA |
1986–1994 |
Population |
M+F |
ST |
Kidney (1,204) |
|
Ye et al. 1999 [107] |
Sweden |
1989–1995 |
Population |
M+F |
Chew, snuff |
Stomach (514) |
|
Lagergren et al. 2000 [108] |
Sweden |
1995–1997 |
Population |
M+F |
Snuff |
Oesophagus (189), stomach (429) |
|
Zheng et al. 2001 [109] |
USA |
NA |
Population |
M+F |
Chew, snuff |
Brain (375) |
|
Schroeder et al. 2002 [110] |
USA |
1980–1982 |
Population |
M |
Chew, snuff, ST |
Non-Hodgkin's lymphoma (182) |
|
Alguacil and Silverman 2004 [111] |
USA |
1986–1989 |
Population |
M+F |
ST |
Pancreas (526) |
|
Bracci and Holly 2005 [112] |
USA |
1988–1993 |
Population |
M |
ST |
Non-Hodgkin's lymphoma (725) |
|
Rosenquist et al. 2005 [113] |
Sweden |
2000–2004 |
Population |
M+F |
Snuff |
Oral (132) |
|
Hassan et al. 2007 [114] |
USA |
2000–2006 |
Hospital |
M+F |
Chew, snuff, ST |
Pancreas (808) |
|
|
||||||
|
a NA = not available. b M = male, F = female, M+F = both sexes. Studies of both sexes with results reported only for males are shown as M. c Only exposures for which results are available are shown. d Oral (oropharyngeal) is defined as in Weitkunat et al. 2007 [4] to include any of the following sites: buccal mucosa, floor of mouth, gingival, gum/palate, lip, oral cavity/mouth, pharynx/alveolus, tongue, tonsils, salivary glands and oral unspecified. This reference also shows the actual sites included for most of the studies included here. For other cancers, more precise definitions of site or histology are given, where relevant, in the tables presenting the findings. Numbers of cases are totals for the sexes specified. Numbers of cases exposed to ST are shown in the tables presenting results by site. e Results were presented for the following 'known tobacco-related' sites: oral (298 cases), oesophagus (72), larynx (119), lung (931) and bladder (306), with comparisons made with all other 'non-related' sites. Results were also presented for various non-related sites: stomach (266), small intestine (19), colon (722), rectum (339), liver (45), gall bladder/bile duct (81), pancreas (224) breast (1,177), cervix (266), uterus (38), ovary (180), vulva (31), prostate (531), male genitalia (53), kidney (126), connective tissue (84), melanoma (99), nervous system (136), thyroid gland (94), lymphosarcoma (121), Hodgkin's disease (84), other lymphomas (33), multiple myeloma (86), leukaemia (172) and other or unknown primaries (385), with comparisons made with all other non-related sites combined. f Includes larynx cancer. g "Attributable oral cancer risk due to smokeless tobacco use based on a case-control study at Sinai Hospital in Detroit"; Perry et al., unpublished. Cited by Gross et al. 1995 [91]. h Australia, Denmark, Germany, Sweden and USA. ST = smokeless tobacco. |
||||||
|
Lee and Hamling BMC Medicine 2009 7:36 doi:10.1186/1741-7015-7-36 |
||||||